Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 2/20 | 0.55 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PDE2A | O00408 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | PNMT | P11086 | 1/20 | 0.45 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ACP3 | P15309 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL316799 | 1.00 | ADRB2 (0.55) | ADRB2ADRB1AOC3CYP2D6NFKB1 | |
| SCHEMBL15943179 | 1.00 | ADRB2 (0.55) | ADRB2ADRB1AOC3CYP2D6NFKB1 | |
| SCHEMBL342944 | 1.00 | ADRB2 (0.55) | ADRB2ADRB1AOC3CYP2D6NFKB1 | |
| SCHEMBL29633572 | 1.00 | ADRB2 (0.55) | ADRB2ADRB1AOC3CYP2D6NFKB1 | |
| SCHEMBL11743000 | 0.88 | ADRB2 (0.46) | ADRB2ADRB1AOC3CYP2D6NFKB1 | |
| SCHEMBL11606505 | 0.81 | TSHR (0.50) | ADRB2ADRB1AOC3CYP2D6NFKB1 | |
| SCHEMBL253300 | 0.81 | ADRB2 (0.52) | ADRB2ADRB1AOC3CYP2D6NFKB1 | |
| SCHEMBL253784 | 0.81 | ADRB2 (0.52) | ADRB2ADRB1AOC3CYP2D6NFKB1 | |
| SCHEMBL253722 | 0.81 | ADRB2 (0.52) | ADRB2ADRB1AOC3CYP2D6NFKB1 | |
| SCHEMBL253301 | 0.81 | ADRB2 (0.52) | ADRB2ADRB1AOC3CYP2D6NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 347 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114292385-B | Nitrogen-containing porous organic polymer composite material and preparation method and application thereof | 苏州大学 | 2023-09-05 | — | — | CN | claimed |
| WO-2023123126-A1 | NITROGEN-CONTAINING POROUS ORGANIC POLYMER COMPOSITE MATERIAL AND PREPARATION METHOD AND APPLICATION THEREOF | 苏州大学 | 2023-07-06 | — | — | WO | claimed |
| CN-114292385-A | Nitrogen-containing porous organic polymer composite material and preparation method and application thereof | 苏州大学 | 2022-04-08 | — | — | CN | claimed |
| EP-3180340-B1 | PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES | HYDRA BIOSCIENCES INC (US) | 2018-10-10 | — | — | EP | claimed |
| EP-3180340-A1 | PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES | Hydra Biosciences, Inc. (US) | 2017-06-21 | — | — | EP | claimed |
| US-9440972-B2 | Pyrido[2,3-d]pyrimidine-2,4(1 H,3H)-dione derivatives | HYDRA BIOSCIENCES, INC. (US) | 2016-09-13 | — | — | US | claimed |
| WO-2016023830-A1 | PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES | HYDRA BIOSCIENCES, INC. (US) | 2016-02-18 | — | — | WO | claimed |
| US-20160046624-A1 | PYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2016-02-18 | — | — | US | claimed |
| EP-2464645-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | Gilead Palo Alto, Inc. (US) | 2012-06-20 | — | — | EP | claimed |
| EP-2137220-A1 | AROMATIC URETHANE ACRYLATES HAVING A HIGH REFRACTIVE INDEX | Bayer MaterialScience AG (DE) | 2009-12-30 | — | — | EP | claimed |
| US-20080312403-A1 | AROMATIC URETHANE ACRYLATES HAVING A HIGH REFRACTIVE INDEX | BAYER MATERIALSCIENCE AG (DE) | 2008-12-18 | — | — | US | claimed |
| WO-2008125199-A1 | AROMATIC URETHANE ACRYLATES HAVING A HIGH REFRACTIVE INDEX | BAYER MATERIALSCIENCE AG (DE) | 2008-10-23 | — | — | WO | claimed |
| US-20260055113-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER | HOFFMANN-LA ROCHE INC. (US) | 2026-02-26 | — | — | US | disclosed |
| EP-4568965-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2025-06-18 | — | — | EP | disclosed |
| WO-2025096957-A1 | RAS-PI3K INHIBITORS AND USES THEREOF | VIVIDION THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| US-12291510-B2 | 2,5-dimercapto-1,3,4-thiadiazole (DMTD) derivatives | THE LUBRIZOL CORPORATION (US) | 2025-05-06 | — | — | US | disclosed |
| EP-0218553-A2 | Process for the preparation of mixtures of metal salts of ring substituted salicylic acid compounds | CIBA-GEIGY AG (CH) | 1987-04-15 | — | — | EP | disclosed |
| EP-0181283-A1 | Isomeric mixtures of metal salicylates, their preparation and utilisation | CIBA-GEIGY AG (CH) | 1986-05-14 | — | — | EP | disclosed |
| EP-0082006-A2 | Method for producing vicinal dihalogenated products and uses thereof, and process for preparing epoxides using the same | CETUS CORPORATION (US) | 1983-06-22 | — | — | EP | disclosed |
| US-4024193-A | Homogeneous hydrogenation process | ICI UNITED STATES INC. (US) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055113-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, CLIC1 | ADRB2 248/4885ADRB1 147/4885AOC3 308/4885 |
| US-12291510-B2 | 2,5-dimercapto-1,3,4-thiadiazole (DMTD) derivatives | DIMT1, PPID, THUMPD1 | ADRB2 3555/4885ADRB1 3972/4885AOC3 929/4885 |
| US-20160046624-A1 | PYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES | TRPC5, P2RX5, HTR5A | ADRB2 61/4885ADRB1 68/4885AOC3 2872/4885 |
| US-20080312403-A1 | AROMATIC URETHANE ACRYLATES HAVING A HIGH REFRACTIVE INDEX | ACR, UTS2R, MUS81 | ADRB2 1273/4885ADRB1 1501/4885AOC3 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.